BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 21386655)

  • 1. Lymphocytes and pancreatic cancer: the effects of these cells on diagnosis and patient survival.
    Pezzilli R; Fabbri D; Imbrogno A
    JOP; 2011 Mar; 12(2):209-10. PubMed ID: 21386655
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene-expression profiling in pancreatic cancer.
    López-Casas PP; López-Fernández LA
    Expert Rev Mol Diagn; 2010 Jul; 10(5):591-601. PubMed ID: 20629509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of nerve growth factor receptors and their prognostic value in human pancreatic cancer.
    Zhang Y; Dang C; Ma Q; Shimahara Y
    Oncol Rep; 2005 Jul; 14(1):161-71. PubMed ID: 15944784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance and regulation of the costimulatory molecule B7-H1 in pancreatic cancer.
    Loos M; Giese NA; Kleeff J; Giese T; Gaida MM; Bergmann F; Laschinger M; W Büchler M; Friess H
    Cancer Lett; 2008 Sep; 268(1):98-109. PubMed ID: 18486325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis.
    Gansauge S; Gansauge F; Ramadani M; Stobbe H; Rau B; Harada N; Beger HG
    Cancer Res; 1997 May; 57(9):1634-7. PubMed ID: 9134998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new platform for gene discovery in pancreatic cancer.
    Callery MP
    Gastroenterology; 2005 Aug; 129(2):763-4. PubMed ID: 16083736
    [No Abstract]   [Full Text] [Related]  

  • 7. [Significance if ICAM-1 on lysis of human pancreatic carcinoma cells by autologous, cytotoxic T-lymphocytes].
    Peiper M; Goedegebuure PS; Eberlein TJ; Broelsch CE
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):59-62. PubMed ID: 14518213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and prognostic value of tuberous sclerosis complex 2 gene product tuberin in human pancreatic cancer.
    Kataoka K; Fujimoto K; Ito D; Koizumi M; Toyoda E; Mori T; Kami K; Doi R
    Surgery; 2005 Sep; 138(3):450-5. PubMed ID: 16213898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of miRNAs in gastrointestinal cancer diagnosis and prognosis.
    Song B; Ju J
    Expert Rev Mol Med; 2010 Oct; 12():e33. PubMed ID: 20942990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in pancreatic cancer: implications of phenotypic and molecular plasticity.
    Reddy JK; Rao MS
    Lab Invest; 1995 Apr; 72(4):383-6. PubMed ID: 7723275
    [No Abstract]   [Full Text] [Related]  

  • 11. Correspondence re: Seki et al., Diagnosis of pancreatic adenocarcinoma by detection of human telomerase reverse transcriptase messenger RNA in pancreatic juice with sample qualification. Clin. Cancer Res., 7: 1976-1981, 2001.
    Hindle KS; Kirkpatrick K; Mokbel K
    Clin Cancer Res; 2002 Feb; 8(2):628-9. PubMed ID: 11839686
    [No Abstract]   [Full Text] [Related]  

  • 12. Thymidylate synthase expression predicts the response to 5-fluorouracil-based adjuvant therapy in pancreatic cancer.
    Hu YC; Komorowski RA; Graewin S; Hostetter G; Kallioniemi OP; Pitt HA; Ahrendt SA
    Clin Cancer Res; 2003 Sep; 9(11):4165-71. PubMed ID: 14519641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basal expression and cytokine induction of intercellular adhesion molecule-1 in human pancreatic cancer cell lines.
    Shimoyama S; Gansauge F; Gansauge S; Kaminishi M; Beger HG
    J Exp Clin Cancer Res; 1999 Mar; 18(1):107-10. PubMed ID: 10374689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implications for survival.
    Bellone G; Smirne C; Mauri FA; Tonel E; Carbone A; Buffolino A; Dughera L; Robecchi A; Pirisi M; Emanuelli G
    Cancer Immunol Immunother; 2006 Jun; 55(6):684-98. PubMed ID: 16094523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-gamma polymorphisms correlate with duration of survival in pancreatic cancer.
    Halma MA; Wheelhouse NM; Barber MD; Powell JJ; Fearon KC; Ross JA
    Hum Immunol; 2004 Nov; 65(11):1405-8. PubMed ID: 15556691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survivin expression and its clinical significance in pancreatic cancer.
    Lee MA; Park GS; Lee HJ; Jung JH; Kang JH; Hong YS; Lee KS; Kim DG; Kim SN
    BMC Cancer; 2005 Oct; 5():127. PubMed ID: 16202147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Periostin, a matrix specific protein, is associated with proliferation and invasion of pancreatic cancer.
    Ben QW; Jin XL; Liu J; Cai X; Yuan F; Yuan YZ
    Oncol Rep; 2011 Mar; 25(3):709-16. PubMed ID: 21225237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical presentation and waiting time targets do not affect prognosis in patients with pancreatic cancer.
    Raptis DA; Fessas C; Belasyse-Smith P; Kurzawinski TR
    Surgeon; 2010 Oct; 8(5):239-46. PubMed ID: 20709279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene cloning of immunogenic antigens overexpressed in pancreatic cancer.
    Nakatsura T; Senju S; Yamada K; Jotsuka T; Ogawa M; Nishimura Y
    Biochem Biophys Res Commun; 2001 Mar; 281(4):936-44. PubMed ID: 11237751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MUC gene family: their role in diagnosis and early detection of pancreatic cancer.
    Ringel J; Löhr M
    Mol Cancer; 2003 Jan; 2():9. PubMed ID: 12556240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.